Centaurea cyanus

Centaurea cyanus (cornflower) contains flavonoids including cyanidin glycosides and polyphenolic compounds such as centaurein and cynaroside, which drive its primary anti-inflammatory activity. These compounds appear to inhibit complement system activation and suppress edema formation by interfering with inflammatory mediator cascades in preclinical models.

Origin & History

Centaurea cyanus, commonly known as cornflower or bachelor's button, is an annual flowering plant in the Asteraceae family native to temperate Europe, particularly the Mediterranean and Northeast regions including Greece, Italy, and Turkey. The flower-head extracts are obtained via standard herbal extraction methods and contain polysaccharides rich in galacturonic acid, arabinose, glucose, rhamnose, and galactose.

Historical & Cultural Context

In European phytotherapy, Centaurea cyanus flower-heads have been traditionally used for treating minor ocular inflammations. Historical use dates back to the Iron Age in Britain and Ireland, where it was known as an archaeophyte with broader applications in herbal medicine.

Health Benefits

• Anti-inflammatory effects demonstrated in animal models (PMID: 10624883) - preliminary evidence only
• Inhibition of edema formation (carrageenan-, zymosan-, and croton oil-induced) - animal studies only
• Complement system modulation through inhibition of plasma hemolytic activity - experimental evidence
• Traditional use for minor ocular inflammations - historical use without clinical validation
• Potential anaphylatoxin activity reduction - based on pharmacological experiments only

How It Works

The flavonoid centaurein and related polyphenols in Centaurea cyanus inhibit plasma hemolytic activity, suggesting interference with the classical or alternative complement cascade at the level of C3 convertase or upstream activation steps. Cyanidin-3-glucoside and cynaroside further suppress pro-inflammatory mediator release, likely by downregulating NF-κB signaling pathways and inhibiting cyclooxygenase activity. These combined actions reduce vascular permeability and leukocyte migration, mechanistically explaining the observed inhibition of carrageenan-, zymosan-, and croton oil-induced edema in rodent models.

Scientific Research

Clinical evidence for Centaurea cyanus is extremely limited, with no human clinical trials, RCTs, or meta-analyses identified. The only available study (PMID: 10624883) demonstrated anti-inflammatory effects of flower-head polysaccharides in animal models, but no human data, sample sizes, or clinical outcomes were reported.

Clinical Summary

Current evidence for Centaurea cyanus is entirely preclinical, derived from animal models with no published randomized controlled trials in humans. In rodent edema models, topical and oral preparations inhibited carrageenan-induced paw edema and croton oil-induced ear edema, though quantified effect sizes and exact dosages vary across studies and have not been validated in human tissue. One experimental study (PMID: 10624883) documented modulation of the complement system via inhibition of plasma hemolytic activity, representing a mechanistically plausible but unconfirmed pathway in humans. The overall evidence strength is low; extrapolation to clinical supplementation is premature without human pharmacokinetic and efficacy data.

Nutritional Profile

Centaurea cyanus (cornflower) is not consumed as a significant food source; it is primarily used as an herbal/medicinal plant and edible flower garnish, so comprehensive macronutrient data per 100 g of fresh petals is limited in peer-reviewed literature. Available phytochemical data includes: **Anthocyanins** – the dominant pigments are protocyanin complex and cyanidin-3-O-(6''-succinylglucoside)-5-O-glucoside (centaurocyanin), with total anthocyanin content in dried flower heads estimated at approximately 1.5–4.0 mg/g dry weight, primarily cyanidin-based glycosides responsible for the characteristic blue color. **Flavonoids** – apigenin, luteolin, quercetin, and their glycosides (e.g., apigenin-4'-O-glucoside, luteolin-7-O-glucoside) are present at approximately 0.5–2.0% of dry weight collectively. **Phenolic acids** – chlorogenic acid, caffeic acid, and protocatechuic acid are reported, contributing to total phenolic content of roughly 15–30 mg gallic acid equivalents (GAE)/g dry extract depending on extraction method. **Sesquiterpene lactones** – including cnicin and related guaianolides at trace to low concentrations (~0.1–0.5% dry weight), which contribute to the anti-inflammatory activity. **Polyacetylenes** – trace amounts reported. **Minerals** – dried flower heads contain potassium (~15–20 mg/g), calcium (~5–10 mg/g), magnesium (~2–4 mg/g), iron (~0.05–0.15 mg/g), and zinc (~0.02–0.05 mg/g) on a dry weight basis (values approximate and dependent on soil/growing conditions). **Vitamins** – no reliable quantitative data on vitamin content exists in peer-reviewed literature; any contribution would be negligible given typical usage quantities (1–3 g dried flowers per cup of tea). **Fiber/Protein** – crude fiber approximately 10–15% and crude protein approximately 8–12% of dry weight in whole flower heads, though these are not nutritionally relevant at typical consumption levels. **Volatile compounds** – small amounts of monoterpenes and sesquiterpenes in the essential oil fraction (<0.1% yield). **Bioavailability notes** – anthocyanin bioavailability is generally low (1–5% absorption in humans); however, cyanidin glycosides may undergo partial hydrolysis in the gut, and metabolites (protocatechuic acid, phenolic acids) are absorbed more efficiently. Flavonoid glycosides have moderate bioavailability improved by gut microbiota-mediated deglycosylation. The plant is typically consumed as an infusion (tea) or tincture, which extracts water-soluble phenolics and anthocyanins effectively but limits extraction of lipophilic sesquiterpene lactones.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are available as human trials are absent. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Chamomile, Calendula, Euphrasia (Eyebright), Rose petals, Elderflower

Safety & Interactions

No formal human safety trials have been conducted for Centaurea cyanus extracts, making definitive risk profiling impossible at this time. Individuals with known allergies to Asteraceae/Compositae family plants (including ragweed, chrysanthemums, and marigolds) face a theoretical cross-reactivity risk and should avoid use. Because cornflower contains compounds that may modulate complement and inflammatory pathways, caution is warranted in individuals taking immunosuppressants, anticoagulants, or NSAIDs, as additive or antagonistic interactions are theoretically possible. Use during pregnancy and breastfeeding is not recommended due to a complete absence of safety data in these populations.